3Yihnaz M, Celen Z, Sevinc A, et al. Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT. Clin Nuel Med, 2009, 34: 598-600.
4Scher B, Seitz M. PET/CT imaging of recurrent prostate cancer. Eur J Nuel Med Mol Imaging, 2008, 35 : 5-8.
5Reske SN. Nuclear imaging of prostate cancer: current status. Ur- ologe A, 2007, 46: 1485-1499.
6Takahashi N, Inoue T, Lee J, et al. The roles of PET and PET/ CT in the diagnosis and management of proslate cancer. Oncolog? , 2007, 72: 226-233.
7Scher B, Seitz M, Albinger W, et al. Value of PET and PET/CT in the diagnostics of prostate and penile cancer. Recent Results, Cancer Res, 2008, 170: 159-179.
8Rinker-Scaeffer, Havkin CW. Location and physical mapping of the PSMA gene to human chromosome 11, Genonics, 1995,30 : 105-108.
9Heston WD. Significance of PSMA. Urology, 1996,35:400-407.
10Carter RE, Feldman AR, Colye ,IT. PSMA is a hydrolase with substrate and pharmacologic characterizations of nearapeptidose. Nat Acad Sci USA, 1996,39:749-753.
